January 12-16, 2013
Orlando, FL, USA
Society for Laboratory Automation and Screening
The SLAS2013 Annual Conference Program Committee invites your abstract submission!
SLAS2013 is a five-day event bringing together more than 5,500 laboratory science and technology scientists, academicians, business leaders and students from around the globe. Scientific session tracks include:
· Assay Development and Screening
· High-Throughput Technologies
· Drug Target Biology
· Micro- and Nanotechnologies
· Bioanalytical Techniques
"ISEH member expertise in the areas of hematology, immunology, stem cell research, cell and gene therapy is welcomed at SLAS2013,” states Steve Hamilton, SLAS director of education. "We invite you to share your knowledge and submit an abstract within one of the scientific tracks noted.”
SLAS2013 keynote speakers are:
Mehmet Toner, Ph.D. is the Helen Andrus Benedict Professor of Biomedical Engineering at the Massachusetts General Hospital, Harvard Medical School and Harvard-MIT Division of Health Sciences and Technology. Scheduled for Monday, January 14, Dr. Toner’s presentation, "Bioengineering and Clinical Applications of the Circulating Tumor Cell Microchip,” will share his integrated strategy to simultaneously advance the engineering and microfluidics of CTC-Chip development, the biology of these rare cells and the potential clinical applications of circulating tumor cells.
Sir Harold "Harry” Kroto, Ph.D. is a Francis Eppes Professor of Chemistry at Florida State University, where he is carrying out research in nanoscience and cluster chemistry. In 1996, Dr. Kroto was one of three recipients of the Nobel Prize for Chemistry, an honor that resulted from his 1985 laboratory experiments that uncovered the existence of C60 Buckminsterfullerene, a new form of carbon. To be presented on Tuesday, January 15, Dr. Kroto will discuss "Science and Society in the 21st Century.”
Charles Sabine is an Emmy-award-winning television journalist who witnessed wars and revolutions as a correspondent for NBC News. Today, he is a spokesperson for patients—and their families—suffering from neurodegenerative disease. At SLAS2013, Mr. Sabine will share the importance of work that occurs within laboratories and the need for scientists to realize how any research is valued by patients and their families. His presentation, "A Perspective on Living with Huntington's Disease,” is scheduled for Wednesday, January 16.
In addition to the scientific podium presentations and three keynote speakers, SLAS2013 includes a full slate of short courses, poster presentations, industry-sponsored tutorials and workshops, as well as an exhibition showcasing more than 325 companies from around the world.
Submit your abstract by Monday, July 30, 2012 at: